Syed Jafri, MD
Urology · Decatur, GANPI 1912183443
Payments from drug & device makers
What this record shows
This record is dominated by education: $17,709 of the $21,118 with a category attached, or 83.9%. Intuitive Surgical accounts for 90.4% of it on its own, with 30 other manufacturers making up the rest. Among urology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 114 payments — averaging $185.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$19K
- Astellas Pharma US Inc$303
- Johnson & Johnson$239
- Blue Earth Diagnostics$155
- Sumitomo Pharma America, Inc.$141
- AbbVie$128
- plus $1K from 25 others
Across 2 payments — averaging $78,000 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medivation LLC.$156K
What the payments were for
- Speaking & faculty fees$5002%
- Food & beverage$2,90914%
- Education$17,70984%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 15 | $19,096 |
| Astellas Pharma US Inc | 13 | $303 |
| Johnson & Johnson(2 entities) | 10 | $239 |
| Blue Earth Diagnostics | 10 | $155 |
| Sumitomo Pharma America, Inc. | 8 | $141 |
| AbbVie(2 entities) | 8 | $128 |
| Dendreon Pharmaceuticals LLC | 4 | $105 |
| Smith+Nephew | 5 | $104 |
| Pfizer | 5 | $101 |
| Novartis | 4 | $94 |
| Merck | 3 | $80 |
| Teleflex LLC | 3 | $67 |
| Avyxa Pharma, LLC | 2 | $59 |
| Bayer | 3 | $59 |
| Endo USA, Inc. | 3 | $58 |
| Tolmar, Inc. | 2 | $37 |
| Medtronic | 1 | $37 |
| Accord Healthcare, Inc. | 2 | $35 |
| Analogic Corporation | 1 | $27 |
| Progenics Pharmaceuticals, Inc. | 1 | $22 |
| Laborie Medical Technologies Corp. | 1 | $20 |
| Antares Pharma, Inc. | 1 | $20 |
| Boston Scientific | 1 | $20 |
| Halozyme Inc | 1 | $17 |
| Baxter Healthcare | 1 | $16 |
| Immunitybio, Inc. | 1 | $15 |
| Tempus AI, Inc | 1 | $14 |
| Olympus America Inc. | 1 | $13 |
| Photocure Inc | 1 | $13 |
| AstraZeneca | 1 | $13 |
| Cook Medical LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$17,050
- DA VINCI SP$2,000
How this compares
$21,118 in reported general payments places this provider in the 90th percentile of 369 urology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 259 | $212,182 |
| Abiraterone Acetate | 84 | $121,219 |
| Mirabegron ErMirabegron | 89 | $56,941 |
| Tamsulosin Hcl | 864 | $14,740 |
| GemtesaVibegron | 17 | $13,192 |
| Finasteride | 448 | $7,762 |
| Trospium Chloride | 67 | $5,648 |
| Methenamine Hippurate | 21 | $3,316 |
| Tolterodine Tartrate ErTolterodine Tartrate | 28 | $3,127 |
| Estradiol | 47 | $3,033 |
| Tadalafil | 29 | $1,566 |
| Silodosin | 14 | $1,415 |
| Testosterone Cypionate | 23 | $1,216 |
| Dutasteride | 33 | $1,114 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 37 | $945 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $303 | $212,182259 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $141 | $13,19217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 369 urology providers in Georgia.
Other urology in Decatur
- Daniel CanterDecatur$329K
- Michael KemperDecatur$72K
- Hemant ChaparalaDecatur$33K
- Vahan KassabianRoswell$1.6M
- Lewis KritemanRoswell$864K
- Tariq HakkyAtlanta$140K
- Sherita KingAugusta$108K
- Brittani Barrett-HarlowFayetteville$100K
- James BennettAtlanta$93K
- Anthony BarnesAtlanta$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.